Literature DB >> 14657126

Dialister invisus sp. nov., isolated from the human oral cavity.

J Downes1, M Munson, W G Wade.   

Abstract

Six strains of anaerobic, Gram-negative coccobacilli isolated from the root canals of patients with endodontic infections (five strains) and from a deep periodontal pocket (one strain) were subjected to a comprehensive range of phenotypic and genetic tests and were found to comprise a homogeneous group. Following 16S rRNA gene sequence analysis, they were found to be most closely related to Dialister pneumosintes, with 93 % sequence similarity between the two taxa. A novel species, Dialister invisus sp. nov., is proposed. Biochemically, the species is largely unreactive and is asaccharolytic, with only traces of acetate and propionate detected as metabolic end-products. The G+C content of the DNA of D. invisus strains is 45-46 mol%. The type strain is E7.25(T) (=CCUG 47026(T)=DSM 15470(T)).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657126     DOI: 10.1099/ijs.0.02640-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  26 in total

1.  Uncultivated phylotypes and newly named species associated with primary and persistent endodontic infections.

Authors:  J F Siqueira; I N Rôças
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

2.  Axenic culture of a candidate division TM7 bacterium from the human oral cavity and biofilm interactions with other oral bacteria.

Authors:  Valeria Soro; Lindsay C Dutton; Susan V Sprague; Angela H Nobbs; Anthony J Ireland; Jonathan R Sandy; Mark A Jepson; Massimo Micaroni; Peter R Splatt; David Dymock; Howard F Jenkinson
Journal:  Appl Environ Microbiol       Date:  2014-08-08       Impact factor: 4.792

3.  Relating the metatranscriptome and metagenome of the human gut.

Authors:  Eric A Franzosa; Xochitl C Morgan; Nicola Segata; Levi Waldron; Joshua Reyes; Ashlee M Earl; Georgia Giannoukos; Matthew R Boylan; Dawn Ciulla; Dirk Gevers; Jacques Izard; Wendy S Garrett; Andrew T Chan; Curtis Huttenhower
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

4.  The nasal microbiome in asthma.

Authors:  Mina Fazlollahi; Tricia D Lee; Jade Andrade; Kasopefoluwa Oguntuyo; Yoojin Chun; Galina Grishina; Alexander Grishin; Supinda Bunyavanich
Journal:  J Allergy Clin Immunol       Date:  2018-03-05       Impact factor: 10.793

5.  Association between tobacco use and the upper gastrointestinal microbiome among Chinese men.

Authors:  Emily Vogtmann; Roberto Flores; Guoqin Yu; Neal D Freedman; Jianxin Shi; Mitchell H Gail; Bruce A Dye; Guo-Qing Wang; Vanja Klepac-Ceraj; Bruce J Paster; Wen-Qiang Wei; Hui-Qin Guo; Sanford M Dawsey; You-Lin Qiao; Christian C Abnet
Journal:  Cancer Causes Control       Date:  2015-02-21       Impact factor: 2.506

Review 6.  Composition and development of oral bacterial communities.

Authors:  Robert J Palmer
Journal:  Periodontol 2000       Date:  2014-02       Impact factor: 7.589

7.  Pyramidobacter piscolens gen. nov., sp. nov., a member of the phylum 'Synergistetes' isolated from the human oral cavity.

Authors:  Julia Downes; Sonia R Vartoukian; Floyd E Dewhirst; Jacques Izard; Tsute Chen; Wen-Han Yu; Iain C Sutcliffe; William G Wade
Journal:  Int J Syst Evol Microbiol       Date:  2009-05       Impact factor: 2.747

8.  Antimicrobial susceptibilities and clinical sources of Dialister species.

Authors:  F Morio; H Jean-Pierre; L Dubreuil; E Jumas-Bilak; L Calvet; G Mercier; R Devine; H Marchandin
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

9.  Anaerobic culture to detect periodontal and caries pathogens.

Authors:  Anne C R Tanner
Journal:  J Oral Biosci       Date:  2015-02

Review 10.  The Role of Fatty Acid Metabolites in Vaginal Health and Disease: Application to Candidiasis.

Authors:  Silke Baldewijns; Mart Sillen; Ilse Palmans; Paul Vandecruys; Patrick Van Dijck; Liesbeth Demuyser
Journal:  Front Microbiol       Date:  2021-07-02       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.